Dermatology and Rheumatology Effective Shared Care AgreementEffective Shared Care Agreement • October 3rd, 2017
This Effective Shared Care Agreement outlines suggested ways in which the prescribing responsibilities can be shared between the specialist and GP. GPs are invited to participate. If the GP is not confident to undertake these roles, then he or she is under no obligation to do so. In such an event, the total clinical responsibility for the patient’s health remains with the specialist.
Dronedarone (Multaq®) for Atrial Fibrillation Effective Shared Care AgreementEffective Shared Care Agreement • September 21st, 2018
This Effective Shared Care Agreement outlines suggested ways in which the prescribing responsibilities can be shared between the specialist and GP. GPs are invited to participate. If the GP is not confident to undertake these roles, then he or she is under no obligation to do so. In such an event, the total clinical responsibility for the patient’s health remains with the specialist.
Effective Shared Care AgreementEffective Shared Care Agreement • January 29th, 2016
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of perampanel for epileptic seizures can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Hydroxycarbamide (Hydrea®) Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • November 14th, 2018
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of hydroxycarbamide for myeloproliferative disorders can be shared between the specialist and general practitioner (GP). You are invited to participate. However, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
THIS FORM IS TO BE USED ONLY WHEN THERE IS A LOCALLY APPROVED SHARED CARE AGREEMENTEffective Shared Care Agreement • August 5th, 2019
The full Effective Shared Care Agreements (ESCAs) and supporting information should be accessed via the North Staffordshire netFormulary:
THIS FORM IS TO BE USED ONLY WHEN THERE IS A LOCALLY APPROVED SHARED CARE AGREEMENTEffective Shared Care Agreement • June 27th, 2019
The full Effective Shared Care Agreements (ESCAs) and supporting information should be accessed via the North Staffordshire netFormulary:
Neurology and Mental Health Effective Shared Care AgreementEffective Shared Care Agreement • November 19th, 2018
This effective shared care agreement (ESCA) sets out details for the sharing of care, for females at risk, receiving medicines containing valproate (Sodium valproate [generic], Epilim, Depakote, Convulex, Episenta, Epival, Kentlim, Orlept, Syonell, Valpal oral tablets, MR tablets, MR capsules, MR granules and oral solution).
Dermatology and Rheumatology Effective Shared Care AgreementEffective Shared Care Agreement • January 16th, 2015
This Effective Shared Care Agreement outlines suggested ways in which the prescribing responsibilities can be shared between the specialist and GP. GPs are invited to participate. If the GP is not confident to undertake these roles, then he or she is under no obligation to do so. In such an event, the total clinical responsibility for the patient’s health remains with the specialist. If a specialist asks the GP to prescribe, the GP should reply to this request as soon as practicable.
EFFECTIVE SHARED CARE AGREEMENT (ESCA)Effective Shared Care Agreement • April 6th, 2016
This information sheet does not replace the Summary of Product Characteristics (SPC), which should be read in conjunction with this guidance. Prescribers should also refer to the appropriate paragraph in the current edition of the BNF.
Effective shared care agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with DEXAMFETAMINEEffective Shared Care Agreement • December 20th, 2018
This form must be completed by the hospital specialist/consultant (may include specialist nurse non-medical prescribers) and sent to the GP for approval. It must be signed by the GP and returned to the team before the patient is informed that the GP will prescribe the medication.
Effective Shared Care AgreementEffective Shared Care Agreement • January 29th, 2016
MYCOPHENOLATEEffective Shared Care Agreement • February 16th, 2016
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of mycophenolate for Connective Tissue Disease can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are not obliged to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with Methylphenidate in AdultsEffective Shared Care Agreement • July 13th, 2016
This form must be completed by the consultant and send to the GP for approval. It must be signed by the GP and returned to the consultant before the patient is informed that the GP will prescribe the drug.
ESCA: Valproate use by women and girls Neurology and Mental Health Effective Shared Care AgreementEffective Shared Care Agreement • October 4th, 2018
This effective shared care agreement (ESCA) sets out details for the sharing of care, for females at risk, receiving medicines containing valproate (Sodium valproate [generic], Epilim, Depakote, Convulex, Episenta, Epival, Kentlim, Orlept, Syonell, Valpal oral tablets, MR tablets, MR capsules, MR granules and oral solution).
Effective shared care agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with DexamfetamineEffective Shared Care Agreement • April 16th, 2018
This form must be completed by the hospital specialist/consultant (may include specialist nurse non-medical prescribers) and sent to the GP for approval. It must be signed by the GP and returned to the team before the patient is informed that the GP will prescribe the medication.
Effective Shared Care AgreementEffective Shared Care Agreement • September 18th, 2013
Dermatology and Rheumatology Effective Shared Care AgreementEffective Shared Care Agreement • December 5th, 2016
This Effective Shared Care Agreement outlines suggested ways in which the prescribing responsibilities can be shared between the specialist and GP. GPs are invited to participate. If the GP is not confident to undertake these roles, then he or she is under no obligation to do so. In such an event, the total clinical responsibility for the patient’s health remains with the specialist. If a specialist asks the GP to prescribe, the GP should reply to this request as soon as practicable.
EFFECTIVE SHARE CARE AGREEMENTEffective Shared Care Agreement • May 30th, 2018
This guidance is not intended to be prescriptive and may be amended according to the individual clinician’s view and patient circumstances.
EFFECTIVE SHARE CARE AGREEMENTEffective Shared Care Agreement • February 12th, 2018
This guidance is not intended to be prescriptive and may be amended according to the individual clinicians view and patient circumstances.
For children of 6 years of age and older with Attention Deficit Hyperactivity Disorder (ADHD) Effective Shared Care AgreementEffective Shared Care Agreement • January 23rd, 2015
This Effective Shared Care Agreement outlines suggested ways in which the prescribing responsibilities can be shared between the specialist and GP. GPs are invited to participate. If the GP is not confident to undertake these roles, then he or she is under no obligation to do so. In such an event, the total clinical responsibility for the patient’s health remains with the specialist.
Effective shared care agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with DEXAMFETAMINEEffective Shared Care Agreement • January 31st, 2019
This form must be completed by the hospital specialist/consultant (may include specialist nurse non-medical prescribers) and sent to the GP for approval. It must be signed by the GP and returned to the team before the patient is informed that the GP will prescribe the medication.
Effective Shared Care AgreementEffective Shared Care Agreement • November 18th, 2016
Effective Shared Care AgreementEffective Shared Care Agreement • July 28th, 2011
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of ibandronic acid in patients with metastatic breast cancer can be shared between the hospital specialist and general practitioner (GP). GPs are invited to participate. If the GP is not confident to undertake these roles, then he or she is under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist. If a specialist asks the GP to prescribe this drug, the GP should reply to this request as soon as practicable.
Effective Shared Care Agreement for the prevention and treatment of rejection following renal transplantationEffective Shared Care Agreement • December 16th, 2009
